Jeff Yass’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
BBA
Jeff Yass's EWTX Position: Q3 2026 in Review
Jeff Yass increased its Edgewise Therapeutics (EWTX) stake by 12,066% in Q3 2026, buying an estimated $29.2M and bringing the position to 692,476 shares worth $28.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2014.
Jeff Yass first reported a position in EWTX in Q1 2023 and has held it in 14 quarters since. 249 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.
- Jeff Yass held 692,476 shares of Edgewise Therapeutics worth $28.1M as of Q3 2026.
- Jeff Yass bought 686,784 Edgewise Therapeutics shares in Q3 2026, an estimated $29.2M.
- Edgewise Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #2014 holding.
- Jeff Yass first reported a position in Edgewise Therapeutics in Q1 2023 and has held it in 14 quarters since.
- 249 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.